Tempus AI (TEM) stock rose 2% after Piper Sandler upgraded it to Overweight with a $76 target, citing Personalis deal and FDA approval as catalysts.

Alumis (ALMS) stock plummeted 56% after Phase 2b lupus trial failure. IFNGS-high subgroup showed promise. Psoriasis NDA filing still planned for Q4 2026.

US stocks declined as 10-year Treasury yields hit 4.75%, oil prices topped $92, and geopolitical concerns pressured markets. Tech sector led losses.

TLDR Amazon shares fall 2.06% as an institutional firm cuts its position by 2.3% AWS…

Pfizer (PFE) stock touched a 52-week high of $29.09 after Q2 earnings exceeded forecasts and the company settled over 6,000 Depo-Provera lawsuits.

MongoDB (MDB) reports Q2 fiscal 2027 earnings Tuesday. Analysts project $1.61 EPS and $735M revenue. Atlas growth and AI adoption are key focus areas.

Apple (AAPL) shares jumped 2.6% as John Ternus became CEO, replacing Tim Cook who led the company to a $4.5 trillion valuation over 15 years.

The U.S. dollar stayed strong near two-week highs as July JOLTS data showed 7.3M job openings, boosting Fed rate hike odds to 74% for the September 17 meeting.

Citi lifts Adobe (ADBE) price target to $301 from $228 before Q3 earnings on Sept 10. Firefly gains traction while legacy Creative faces competition.

Howmet Aerospace (HWM) stock rebounds 3.5% as top analysts call SpaceX selloff overdone, with price targets implying 34% upside. Long-term deals intact.

Hut 8 (HUT) stock rises as Anthropic’s $35B AI computing agreement with Nvidia-backed Lambda includes the company’s Texas Beacon Point data center campus.

BioAffinity Technologies (BIAF) stock rallied 55% after revealing CyPath Lung’s potential to monitor lung cancer survivors for recurrence. Volume hit 17M shares.